128 related articles for article (PubMed ID: 25245988)
1. Discovery of novel DUSP16 phosphatase inhibitors through virtual screening with homology modeled protein structure.
Park H; Park SY; Nam SW; Ryu SE
J Biomol Screen; 2014 Dec; 19(10):1383-90. PubMed ID: 25245988
[TBL] [Abstract][Full Text] [Related]
2. Identification of potent VHZ phosphatase inhibitors with structure-based virtual screening.
Park H; Park SY; Oh JJ; Ryu SE
J Biomol Screen; 2013 Feb; 18(2):226-31. PubMed ID: 23042075
[TBL] [Abstract][Full Text] [Related]
3. Identification of novel dual-specificity phosphatase 26 inhibitors by a hybrid virtual screening approach based on pharmacophore and molecular docking.
Ren JX; Cheng Z; Huang YX; Zhao JF; Guo P; Zou ZM; Xie Y
Biomed Pharmacother; 2017 May; 89():376-385. PubMed ID: 28249240
[TBL] [Abstract][Full Text] [Related]
4. Homology modeling and virtual screening approaches to identify potent inhibitors of slingshot phosphatase 1.
Park H; Park SY; Ryu SE
J Mol Graph Model; 2013 Feb; 39():65-70. PubMed ID: 23220283
[TBL] [Abstract][Full Text] [Related]
5. Virtual screening and biochemical evaluation to identify new inhibitors of mammalian target of rapamycin (mTOR).
Park H; Choe H; Hong S
Bioorg Med Chem Lett; 2014 Feb; 24(3):835-8. PubMed ID: 24393580
[TBL] [Abstract][Full Text] [Related]
6. Discovery of potent inhibitors of receptor protein tyrosine phosphatase sigma through the structure-based virtual screening.
Park H; Chien PN; Ryu SE
Bioorg Med Chem Lett; 2012 Oct; 22(20):6333-7. PubMed ID: 22989533
[TBL] [Abstract][Full Text] [Related]
7. Identification of novel PTPRQ phosphatase inhibitors based on the virtual screening with docking simulations.
Park H; Yu KR; Ku B; Kim BY; Kim SJ
Theor Biol Med Model; 2013 Aug; 10():49. PubMed ID: 23981594
[TBL] [Abstract][Full Text] [Related]
8. Structure-based virtual screening approach to the discovery of novel PTPMT1 phosphatase inhibitors.
Park H; Kim SY; Kyung A; Yoon TS; Ryu SE; Jeong DG
Bioorg Med Chem Lett; 2012 Jan; 22(2):1271-5. PubMed ID: 22115589
[TBL] [Abstract][Full Text] [Related]
9. Structure-based virtual screening approach to identify novel classes of PTP1B inhibitors.
Park H; Bhattarai BR; Ham SW; Cho H
Eur J Med Chem; 2009 Aug; 44(8):3280-4. PubMed ID: 19269068
[TBL] [Abstract][Full Text] [Related]
10. Discovery of novel alpha-glucosidase inhibitors based on the virtual screening with the homology-modeled protein structure.
Park H; Hwang KY; Oh KH; Kim YH; Lee JY; Kim K
Bioorg Med Chem; 2008 Jan; 16(1):284-92. PubMed ID: 17920282
[TBL] [Abstract][Full Text] [Related]
11. Virtual Screening with Docking Simulations and Biochemical Evaluation of VHY Phosphatase Inhibitors.
Park H; Lee HS; Kim SJ
Chem Pharm Bull (Tokyo); 2015; 63(10):807-11. PubMed ID: 26423037
[TBL] [Abstract][Full Text] [Related]
12. Identification of novel inhibitors of mitogen-activated protein kinase phosphatase-1 with structure-based virtual screening.
Park H; Jeon JY; Kim SY; Jeong DG; Ryu SE
J Comput Aided Mol Des; 2011 May; 25(5):469-75. PubMed ID: 21567231
[TBL] [Abstract][Full Text] [Related]
13. Identification of novel inhibitors of tropomyosin-related kinase A through the structure-based virtual screening with homology-modeled protein structure.
Park H; Chi O; Kim J; Hong S
J Chem Inf Model; 2011 Nov; 51(11):2986-93. PubMed ID: 22017333
[TBL] [Abstract][Full Text] [Related]
14. Structure-based virtual screening approach to the discovery of phosphoinositide 3-kinase alpha inhibitors.
Park H; Choi H; Hong S; Kim D; Oh DS; Hong S
Bioorg Med Chem Lett; 2011 Apr; 21(7):2021-4. PubMed ID: 21354792
[TBL] [Abstract][Full Text] [Related]
15. Structure-based virtual screening approach to identify novel classes of Cdc25B phosphatase inhibitors.
Park H; Li M; Choi J; Cho H; Ham SW
Bioorg Med Chem Lett; 2009 Aug; 19(15):4372-5. PubMed ID: 19500977
[TBL] [Abstract][Full Text] [Related]
16. Structure-based virtual screening approach to the discovery of p38 MAP kinase inhibitors.
Choi H; Park HJ; Shin JC; Ko HS; Lee JK; Lee S; Park H; Hong S
Bioorg Med Chem Lett; 2012 Mar; 22(6):2195-9. PubMed ID: 22342625
[TBL] [Abstract][Full Text] [Related]
17. Discovery of novel Cdc25 phosphatase inhibitors with micromolar activity based on the structure-based virtual screening.
Park H; Bahn YJ; Jung SK; Jeong DG; Lee SH; Seo I; Yoon TS; Kim SJ; Ryu SE
J Med Chem; 2008 Sep; 51(18):5533-41. PubMed ID: 18714978
[TBL] [Abstract][Full Text] [Related]
18. A docking study of enhanced intracellular survival protein from Mycobacterium tuberculosis with human DUSP16/MKP-7.
Yoon HJ; Kim KH; Yang JK; Suh SW; Kim H; Jang S
J Synchrotron Radiat; 2013 Nov; 20(Pt 6):929-32. PubMed ID: 24121342
[TBL] [Abstract][Full Text] [Related]
19. Structure-based virtual screening approach to the discovery of novel inhibitors of eyes absent 2 phosphatase with various metal chelating moieties.
Park H; Jung SK; Yu KR; Kim JH; Kim YS; Ko JH; Park BC; Kim SJ
Chem Biol Drug Des; 2011 Oct; 78(4):642-50. PubMed ID: 21777393
[TBL] [Abstract][Full Text] [Related]
20. An allosteric site on MKP5 reveals a strategy for small-molecule inhibition.
Gannam ZTK; Min K; Shillingford SR; Zhang L; Herrington J; Abriola L; Gareiss PC; Pantouris G; Tzouvelekis A; Kaminski N; Zhang X; Yu J; Jamali H; Ellman JA; Lolis E; Anderson KS; Bennett AM
Sci Signal; 2020 Aug; 13(646):. PubMed ID: 32843541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
